TELA Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
TELA Bio, Inc. (TELA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 322.47 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-11
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 232.48K shares, a 1298.89% increase year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 89.99K shares, a 381.59% increase year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 46.71K shares, a 382.62% increase year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 162.51K shares, a 47.36% increase year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 244.52K shares, a 7.64% decline from fiscal 2024.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 264.74K shares, a 173.13% increase from fiscal 2023.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 96.93K shares, a 19.06% increase from fiscal 2022.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 81.41K shares, a 55.43% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 232.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 322.47K shares 10-Q · filed 2026-08-11 | 369.18K shares derived: sum of 3 quarters · filed 2026-08-11 | 531.69K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 89.99K shares 10-Q · filed 2026-05-13 | 136.70K shares derived: sum of 2 quarters · filed 2026-05-13 | 299.21K shares derived: sum of 3 quarters · filed 2026-05-13 | 315.82K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 46.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 209.22K shares derived: sum of 2 quarters · filed 2026-03-25 | 225.84K shares derived: sum of 3 quarters · filed 2026-03-25 | 244.52K shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 162.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 179.13K shares derived: sum of 2 quarters · filed 2025-11-14 | 197.81K shares 10-Q · filed 2025-11-14 | 207.49K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | 16.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 35.30K shares 10-Q · filed 2025-08-11 | 44.98K shares derived: sum of 3 quarters · filed 2026-03-25 | 155.26K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | 18.68K shares 10-Q · filed 2025-05-08 | 28.36K shares derived: sum of 2 quarters · filed 2026-03-25 | 138.64K shares derived: sum of 3 quarters · filed 2026-03-25 | 219.90K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | 9.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 119.96K shares derived: sum of 2 quarters · filed 2026-03-25 | 201.22K shares derived: sum of 3 quarters · filed 2026-03-25 | 264.74K shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 110.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 191.54K shares derived: sum of 2 quarters · filed 2024-11-08 | 255.06K shares 10-Q · filed 2024-11-08 | 289.00K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | 81.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 144.78K shares 10-Q · filed 2024-08-13 | 178.72K shares derived: sum of 3 quarters · filed 2026-03-25 | 195.16K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | 63.52K shares 10-Q · filed 2024-05-10 | 97.46K shares derived: sum of 2 quarters · filed 2026-03-25 | 113.90K shares derived: sum of 3 quarters · filed 2026-03-25 | 140.15K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | 33.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 50.38K shares derived: sum of 2 quarters · filed 2026-03-25 | 76.63K shares derived: sum of 3 quarters · filed 2026-03-25 | 96.93K shares 10-K · filed 2026-03-25 |
| 2023-09-30 | 16.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 42.69K shares derived: sum of 2 quarters · filed 2023-11-13 | 62.99K shares 10-Q · filed 2023-11-13 | 69.02K shares derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | 26.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 46.55K shares 10-Q · filed 2023-08-10 | 52.58K shares derived: sum of 3 quarters · filed 2025-03-21 | 60.66K shares derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | 20.30K shares 10-Q · filed 2023-05-11 | 26.33K shares derived: sum of 2 quarters · filed 2025-03-21 | 34.42K shares derived: sum of 3 quarters · filed 2025-03-21 | 43.36K shares derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | 6.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 14.12K shares derived: sum of 2 quarters · filed 2025-03-21 | 23.06K shares derived: sum of 3 quarters · filed 2025-03-21 | 81.41K shares 10-K · filed 2025-03-21 |
| 2022-09-30 | 8.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 17.03K shares derived: sum of 2 quarters · filed 2022-11-10 | 75.38K shares 10-Q · filed 2022-11-10 | 82.04K shares derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | 8.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 67.29K shares 10-Q · filed 2022-08-11 | 73.96K shares derived: sum of 3 quarters · filed 2024-03-22 | 107.46K shares derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | 58.35K shares 10-Q · filed 2022-05-11 | 65.02K shares derived: sum of 2 quarters · filed 2024-03-22 | 98.51K shares derived: sum of 3 quarters · filed 2024-03-22 | 199.66K shares derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | 6.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | 40.16K shares derived: sum of 2 quarters · filed 2024-03-22 | 141.31K shares derived: sum of 3 quarters · filed 2024-03-22 | 182.65K shares 10-K · filed 2024-03-22 |
| 2021-09-30 | 33.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 134.64K shares derived: sum of 2 quarters · filed 2021-11-12 | 175.98K shares 10-Q · filed 2021-11-12 | 185.44K shares derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | 101.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 142.48K shares 10-Q · filed 2021-08-12 | 151.94K shares derived: sum of 3 quarters · filed 2023-03-23 | 187.94K shares derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | 41.34K shares 10-Q · filed 2021-05-14 | 50.80K shares derived: sum of 2 quarters · filed 2023-03-23 | 86.80K shares derived: sum of 3 quarters · filed 2023-03-23 | 102.20K shares derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | 9.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 45.46K shares derived: sum of 2 quarters · filed 2023-03-23 | 60.87K shares derived: sum of 3 quarters · filed 2023-03-23 | 70.04K shares 10-K · filed 2023-03-23 |
| 2020-09-30 | 36.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 51.40K shares derived: sum of 2 quarters · filed 2020-11-12 | 60.58K shares 10-Q · filed 2020-11-12 | 82.66K shares derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | 15.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 24.57K shares 10-Q · filed 2020-08-13 | 46.66K shares derived: sum of 3 quarters · filed 2022-03-23 | |
| 2020-03-31 | 9.17K shares 10-Q · filed 2020-05-15 | 31.25K shares derived: sum of 2 quarters · filed 2022-03-23 | ||
| 2019-12-31 | 22.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 43.70K shares 10-K · filed 2022-03-23 | ||
| 2019-09-30 | 21.61K shares 10-Q · filed 2019-12-18 | |||
| 2018-12-31 | 11.90K shares 10-K · filed 2021-03-25 | |||
| 2017-12-31 | 14.77K shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |